Vitamin D receptor binding, chromatin states and association with multiple sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin D receptor binding, chromatin states and association with multiple sclerosis
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 21, Issue 16, Pages 3575-3586
Publisher
Oxford University Press (OUP)
Online
2012-05-18
DOI
10.1093/hmg/dds189
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The evidence for a role of B cells in multiple sclerosis
- (2012) G. Disanto et al. NEUROLOGY
- Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells
- (2012) Giulio Disanto et al. PLoS One
- Rare variants in the CYP27B1 gene are associated with multiple sclerosis
- (2011) Sreeram V. Ramagopalan et al. ANNALS OF NEUROLOGY
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Mapping and analysis of chromatin state dynamics in nine human cell types
- (2011) Jason Ernst et al. NATURE
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Chromatin accessibility pre-determines glucocorticoid receptor binding patterns
- (2011) Sam John et al. NATURE GENETICS
- The Genomic HyperBrowser: inferential genomics at the sequence level
- (2011) Geir K Sandve et al. GENOME BIOLOGY
- A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution
- (2010) S. V. Ramagopalan et al. GENOME RESEARCH
- Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity
- (2010) Diane L. Kamen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Vitamin D and multiple sclerosis
- (2010) Alberto Ascherio et al. LANCET NEUROLOGY
- Multiple sclerosis: risk factors, prodromes, and potential causal pathways
- (2010) Sreeram V Ramagopalan et al. LANCET NEUROLOGY
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
- (2010) Johannes Brettschneider et al. PLoS One
- Circos: An information aesthetic for comparative genomics
- (2009) M. Krzywinski et al. GENOME RESEARCH
- Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
- (2009) Melanie Bahlo et al. NATURE GENETICS
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
- (2009) Philip L De Jager et al. NATURE GENETICS
- Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
- (2009) F. Sellebjerg et al. NEUROLOGY
- Multiple sclerosis immunology: The healthy immune system vs the MS immune system
- (2009) L. H. Kasper et al. NEUROLOGY
- IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
- (2009) Johannes Brettschneider et al. PLoS One
- Multiple sclerosis: major histocompatibility complexity and antigen presentation
- (2009) Sreeram V Ramagopalan et al. Genome Medicine
- CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients
- (2008) F G Joseph et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More